117 related articles for article (PubMed ID: 2421742)
1. [Medical and commercial aspects of human interferon].
von Eichborn JF
Arzneimittelforschung; 1986 Feb; 36(2):279-82. PubMed ID: 2421742
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology and toxicology of the interferons: an overview.
Mannering GJ; Deloria LB
Annu Rev Pharmacol Toxicol; 1986; 26():455-515. PubMed ID: 2424363
[TBL] [Abstract][Full Text] [Related]
3. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
Billiau A
J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
[TBL] [Abstract][Full Text] [Related]
4. [The interferon system. A review of biological principles and clinical uses].
Schneider FJ
Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
[TBL] [Abstract][Full Text] [Related]
5. [Human interferons: biological and clinical promises and premises].
Jasmin C
Schweiz Med Wochenschr; 1991 Mar; 121(13):463-6. PubMed ID: 1709521
[TBL] [Abstract][Full Text] [Related]
6. Characterization of interferons produced by peripheral blood mononuclear cells from healthy subjects in response to Corynebacterium parvum or poly I: poly C.
Hertzog PJ; Cheetham BF; Sexton JL; Linnane AW
Biochem Int; 1989 Dec; 19(6):1427-36. PubMed ID: 2483976
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of interferon in viral infections.
Levin S
Isr J Med Sci; 1983 Nov; 19(11):955-8. PubMed ID: 6198305
[No Abstract] [Full Text] [Related]
8. A practitioner's guide to interferon.
Warren SL
Ann Allergy; 1980 Jul; 45(1):37-42. PubMed ID: 6157337
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of interferons with chemotherapeutic agents].
Kimoto Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):293-301. PubMed ID: 3080964
[TBL] [Abstract][Full Text] [Related]
10. [Update on the use of interferons in clinical practice].
Lauta VM
Clin Ter; 1995; 146(6-7):393-448. PubMed ID: 7586995
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
12. Interferon production by human peripheral lymphocytes in response to measles virus.
Nakayama T; Urano T; Osano M; Maehara N; Hashimoto H; Nakagawa M; Sasaki K; Unno S; Makino S
Kitasato Arch Exp Med; 1987 Jun; 60(1-2):41-9. PubMed ID: 2444736
[No Abstract] [Full Text] [Related]
13. [Possibilities and limits of the use of interferons in the clinic].
Ludwig CU
Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
[TBL] [Abstract][Full Text] [Related]
14. [Interferon system in viral hepatitis].
Lisker Melman M
Rev Invest Clin; 1990 Jul; 42 Suppl():92-6. PubMed ID: 19256144
[TBL] [Abstract][Full Text] [Related]
15. Production of human interferons: an overview.
Mizrahi A
Dev Biol Stand; 1983; 55():219-30. PubMed ID: 6203796
[TBL] [Abstract][Full Text] [Related]
16. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
Naldini A; Fleischmann WR
J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
[TBL] [Abstract][Full Text] [Related]
17. Current view on the perspectives of interferon therapy.
Borecký L
Acta Virol; 1986 Mar; 30(2):161-9. PubMed ID: 2425613
[TBL] [Abstract][Full Text] [Related]
18. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
19. Interferons: not just alpha.
Krown SE
Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773
[No Abstract] [Full Text] [Related]
20. [Combined effect of interferons alpha, beta and gamma on tumor growth in vitro].
Kimoto Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):302-7. PubMed ID: 3080965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
